Molecular Pathology
Molecular Pathology provides a full range of diagnostic services for hematolymphoid malignancies and solid tumors. Depending on the assay, the core can perform molecular diagnosis on blood, bone marrow, body fluids, and fresh, frozen, or paraffin-embedded tissues. The core facilitates, implements and supports the needs of basic science researchers, clinical researchers, population researchers and clinical science collaborations.
Across all its efforts, Molecular Pathology emphasizes the pursuit of institutional collaborations, seeking and enabling opportunities for laboratories to work closely together.
Meet the Team
Leadership
Contact the Team
Using the Facility
Services currently offered by the Research Molecular Pathology facility:
- Study design and protocol review
- Targeted DNA sequencing and data interpretation
- Gene expression assays (Nanostring nCounter)
- Tissue based digital spatial profiling (GeoMx)
- Circulating tumor cell isolation (DEParray)
- Digital PCR and RNA in- situ hybridization (RNAscope) services
- Initial consultation on research projects
- Participation in collaborative writing
Current pricing can be found on iLab Solutions.
In a given year, City of Hope conducts more than 400 clinical trials enrolling more than 6,000 patients.
City of Hope is focused on basic and clinical research in cancer, diabetes and other life-threatening diseases.
